BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26330014)

  • 1. Fra-1 is upregulated in gastric cancer tissues and affects the PI3K/Akt and p53 signaling pathway in gastric cancer.
    He J; Zhu G; Gao L; Chen P; Long Y; Liao S; Yi H; Yi W; Pei Z; Wu M; Li X; Xiang J; Peng S; Ma J; Zhou M; Xiong W; Zeng Z; Xiang B; Tang K; Cao L; Li G; Zhou Y
    Int J Oncol; 2015 Nov; 47(5):1725-34. PubMed ID: 26330014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fra-1 is upregulated in lung cancer tissues and inhibits the apoptosis of lung cancer cells by the P53 signaling pathway.
    Zhong G; Chen X; Fang X; Wang D; Xie M; Chen Q
    Oncol Rep; 2016 Jan; 35(1):447-53. PubMed ID: 26549498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fra-1 is downregulated in cervical cancer tissues and promotes cervical cancer cell apoptosis by p53 signaling pathway in vitro.
    Xiao S; Zhou Y; Yi W; Luo G; Jiang B; Tian Q; Li Y; Xue M
    Int J Oncol; 2015 Apr; 46(4):1677-84. PubMed ID: 25651840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YWHAH activates the HMGA1/PI3K/AKT/mTOR signaling pathway by positively regulating Fra-1 to affect the proliferation of gastric cancer cells.
    He J; Zeng F; Jin XI; Liang L; Gao M; Li W; Li G; Zhou Y
    Oncol Res; 2023; 31(4):615-630. PubMed ID: 37415737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FRA-1 suppresses apoptosis of Helicobacter pylori infected MGC-803 cells.
    Yang Y; You B; Dong S; Zhou C
    Mol Biol Rep; 2021 Jan; 48(1):611-621. PubMed ID: 33389529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD90 is upregulated in gastric cancer tissues and inhibits gastric cancer cell apoptosis by modulating the expression level of SPARC protein.
    Zhu GC; Gao L; He J; Long Y; Liao S; Wang H; Li X; Yi W; Pei Z; Wu M; Xiang J; Peng S; Ma J; Zhou M; Zeng Z; Xiang B; Xiong W; Tang K; Cao L; Li X; Li G; Zhou Y
    Oncol Rep; 2015 Nov; 34(5):2497-506. PubMed ID: 26329007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD38 is highly expressed and affects the PI3K/Akt signaling pathway in cervical cancer.
    Liao S; Xiao S; Zhu G; Zheng D; He J; Pei Z; Li G; Zhou Y
    Oncol Rep; 2014 Dec; 32(6):2703-9. PubMed ID: 25310288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
    Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
    Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gankyrin promotes the proliferation of gastric cancer and is associated with chemosensitivity.
    Zeng YC; Sun D; Li WH; Zhao J; Xin Y
    Tumour Biol; 2017 Jun; 39(6):1010428317704820. PubMed ID: 28653901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer.
    Lin HL; Yang MH; Wu CW; Chen PM; Yang YP; Chu YR; Kao CL; Ku HH; Lo JF; Liou JP; Chi CW; Chiou SH
    Int J Cancer; 2007 Dec; 121(11):2547-55. PubMed ID: 17680560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis.
    Kang MJ; Ryu BK; Lee MG; Han J; Lee JH; Ha TK; Byun DS; Chae KS; Lee BH; Chun HS; Lee KY; Kim HJ; Chi SG
    Gastroenterology; 2008 Dec; 135(6):2030-42, 2042.e1-3. PubMed ID: 18824170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
    Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
    Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K/AKT signaling pathway.
    Cheng Y; Li Y; Liu D; Zhang R; Zhang J
    FEBS Lett; 2014 Aug; 588(17):3274-81. PubMed ID: 25064845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance of PI3K, Akt and survivin expression in gastric cancer.
    Gu Y; Jin S; Wang F; Hua Y; Yang L; Shu Y; Zhang Z; Guo R
    Biomed Pharmacother; 2014 May; 68(4):471-5. PubMed ID: 24726064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
    Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
    Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells.
    Liang J; Ge F; Guo C; Luo G; Wang X; Han G; Zhang D; Wang J; Li K; Pan Y; Yao L; Yin Z; Guo X; Wu K; Ding J; Fan D
    FEBS J; 2009 Feb; 276(3):685-94. PubMed ID: 19143835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
    Lu WD; Zuo Y; Xu Z; Zhang M
    World J Gastroenterol; 2015 Apr; 21(15):4564-73. PubMed ID: 25914465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dracorhodin perchlorate inhibits PI3K/Akt and NF-κB activation, up-regulates the expression of p53, and enhances apoptosis.
    Rasul A; Ding C; Li X; Khan M; Yi F; Ali M; Ma T
    Apoptosis; 2012 Oct; 17(10):1104-19. PubMed ID: 22711363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population.
    Triantafyllou K; Kitsanta P; Karamanolis DG; Kittas C; Ladas SD
    Dig Liver Dis; 2008 Jan; 40(1):39-45. PubMed ID: 18063429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD24 promotes the proliferation and inhibits the apoptosis of cervical cancer cells in vitro.
    Pei Z; Zhu G; Huo X; Gao L; Liao S; He J; Long Y; Yi H; Xiao S; Yi W; Chen P; Li X; Li G; Zhou Y
    Oncol Rep; 2016 Mar; 35(3):1593-601. PubMed ID: 26707501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.